Immunogenicity of a prophylactic quadrivalent human papillomavirus L1 virus-like particle vaccine in male and female adolescent transplant recipients

Pediatric Transplantation

Volumn 18, Issue 3, 2014, Pages 310-315

  Gomez Lobo, V ^a,b   Whyte, T ^c   Kaufman, S ^c   Torres, C ^a   Moudgil, A ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

adolescent; human papillomavirus; immunogenicity; kidney; liver; transplantation; vaccine

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; QUADRIVALENT HUMAN PAPILLOMAVIRUS L1 VIRUS LIKE PARTICLE VACCINE; RAPAMYCIN; TACROLIMUS; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS LIKE PARTICLE VACCINE; WART VIRUS VACCINE; HUMAN PAPILLOMAVIRUS VACCINE L1, TYPE 6,11,16,18; IMMUNOSUPPRESSIVE AGENT;

ACNE; ADOLESCENT; ADULT; ANTIBODY PRODUCTION; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; DIARRHEA; FEMALE; FEVER; GRAFT RECIPIENT; HEADACHE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INJECTION SITE PAIN; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; PAPILLOMAVIRUS INFECTION; PNEUMONIA; SEROCONVERSION; SWELLING; VACCINATION; BLOOD; CLINICAL TRIAL; COMPLICATION; IMMUNOASSAY; IMMUNOLOGY; KIDNEY; LIVER; LIVER FAILURE; PAPILLOMAVIRUS INFECTIONS; RENAL INSUFFICIENCY; VIROLOGY;

ADOLESCENT; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CHILD; FEMALE; HUMAN PAPILLOMAVIRUS 11; HUMANS; IMMUNOASSAY; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; LIVER; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; RENAL INSUFFICIENCY; TRANSPLANT RECIPIENTS; VACCINATION; VACCINES, VIRUS-LIKE PARTICLE;

EID: 84898486157     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/petr.12226     Document Type: Article

References (25)

1. Penn I,. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl 1998: 147-158.
2. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C,. Cancer after kidney transplantation in the United States. Am J Transplant 2004: 4: 905-913.
3. De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S,. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta-analysis. Int J Cancer 2009: 124: 1626-1636.
4. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007: 356: 1944-1956.
5. Badawi H, Ahmed H, Ismail A, et al. Role of human papillomavirus types 16, 18, and 52 in recurrent cystitis and urinary bladder cancer among Egyptian patients. Medscape J Med 2008: 10: 232.
6. FDA Licenses New Vaccine for Prevention of Cervical Cancer and Other Diseases in Females Caused by Human Papillomavirus. Available at: http://www.fda.gov/bbs/topics/news/2006/new01385.html (accessed June 21, 2013).
7. Villa LL, Costa RL, Petta CA, et al. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer 2006: 95: 1459-1466.
8. Joura EA, Kjaer SK, Wheeler CM, et al. HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine. Vaccine 2008: 26: 6844-6851.
9. F uture II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007: 356: 1915-1927.
10. Villa LL,. Overview of the clinical development and results of a quadrivalent HPV (types 6, 11, 16, 18) vaccine. Int J Infect Dis 2007: 11 (Suppl 2): S17-S25.
11. Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 2004: 4 (Suppl 10): 160-163.
12. Carey W, Pimentel R, Westveer MK, Vogt D, Broughan T,. Failure of hepatitis B immunization in liver transplant recipients: Results of a prospective trial. Am J Gastroenterol 1990: 85: 1590-1592.
13. Loinaz C, de Juanes JR, Gonzalez EM, et al. Hepatitis B vaccination results in 140 liver transplant recipients. Hepatogastroenterology 1997: 44: 235-238.
14. Duca P, Del Pont JM, D'Agostino D,. Successful immune response to a recombinant hepatitis B vaccine in children after liver transplantation. J Pediatr Gastroenterol Nutr 2001: 32: 168-170.
15. Lefebure AF, Verpooten GA, Couttenye MM, De Broe ME,. Immunogenicity of a recombinant DNA hepatitis B vaccine in renal transplant patients. Vaccine 1993: 11: 397-399.
16. Block SL, Nolan T, Sattler C, et al.; Protocol 016 Study Group. Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women. Pediatrics 2006: 118: 2135-2145.
17. Rendi-Wagner P, Kundi M, Stemberger H, et al. Antibody-response to three recombinant hepatitis B vaccines: Comparative evaluation of multicenter travel-clinic based experience. Vaccine 2001: 19: 2055-2060.
18. Kumar D, Unger ER, Panicker G, Mdvedev P, Wilson L, Humar A,. Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients. Am J Transplant 2013: 13: 2411-2417.
19. Dobson SR, McNeil S, Dionne M, et al. Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: A randomized clinical trial. JAMA 2013: 309: 1793-1802.
20. Katerinis I, Hadaya K, Duquesnoy R, et al. De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients. Am J Transplant 2011: 11: 1727-1733.
21. Schaffer SA, Husain S, Delgado DH, Kavanaugh L, Ross HJ,. Impact of adjuvant H1N1 vaccine on cell-mediated rejection in heart transplant recipients. Am J Transplant 2011: 11: 2751-2754.
22. Magnani G, Falchetti E, Pollini G, et al. Safety and efficacy of two types of influenza vaccination in heart transplant recipients: A prospective randomized controlled study. J Heart Lung Transplant 2005: 24: 588-592.
23. Hsiau M, Fernandez HE, Gjertson D, Ettenger RB, Tsai EW,. Monitoring nonadherence and acute rejection with variation in blood immunosuppressant levels in pediatric renal transplantation. Transplantation 2011: 92: 918-922.
24. Chaudhuri A, Ozawa M, Everly MJ, et al. The clinical impact of humoral immunity in pediatric renal transplantation. J Am Soc Nephrol 2013: 24: 655-664.
25. Sis B, Jhangri GS, Riopel J, et al. New diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am J Transplant 2012: 12: 1168-1179.